Purified recombinant protein o
f Human bone morphogenetic protein 4 (BMP4), transcript variant 1, Ser293-End, with N-terminal T7 tag, expressed in E.coli, 50ug- ￥2840
- OriGene
- TP750186
- 2026年03月19日
企业认证
相关产品推荐更多 >
Purified recombinant protein of Mouse fermitin family member 1 (Fermt1), with C-terminal MYC/DDK tag, expressed in HEK293T cells, 20ug
￥2900Purified recombinant protein of Human DAZ associated protein 2 (DAZAP2), transcript variant 3, full length, with N-terminal HIS tag, expressed in E.coli, 50ug
￥2040Purified recombinant protein of Human IKAROS family zinc finger 2 (Helios) (IKZF2), transcript variant 2, 50ug
￥2480
Recombinant protein of human activating signal cointegrator 1 complex subunit 1 (ASCC1)
￥2900Purified recombinant protein of Human zinc finger protein 101 (ZNF101), full length, with N-terminal HIS tag, expressed in E.Coli, 50ug
￥2040
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Store at -80°C.
- 保质期：
Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.
- 英文名：
Purified recombinant protein of Human bone morphogenetic protein 4 (BMP4), transcript variant 1, Ser293-End, with N-terminal T7 tag, expressed in E.coli, 50ug
- 供应商：
OriGene
- 规格：
50 ug
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Protein Microarrays for Identification of Novel Extracellular Protein‐Protein Interactions
Basic Protocol 1: Production of Extracellular Protein Microarrays Materials Purified proteins
Quantitative Proteome and Phosphoproteome Analysis of Human Pluripotent Stem Cells
(MS)-based phosphoproteomics strategy applied to monitor phosphorylation dynamics after bone morphogenetic protein 4 (BMP4)-induced differentiation of human embryonic stem cells (hESCs). Our method combines the use of strong cation exchange (SCX) and titanium
Directed Differentiation of Human Embryonic Stem Cells to Epidermal Progenitors
subpopulations are required. Here we describe a robust strategy for generating cytokeratin 14+ (K14+)/p63+ keratinocyte progenitors from hES cells through stage-specific application of retinoic acid (RA) and bone morphogenetic protein-4 (BMP4). Induction
技术资料暂无技术资料 索取技术资料
